Esquire Financial executive disposes of 5,181 shares at $104.04
Esquire Financial Holdings, Inc. reported an insider transaction by a senior executive who serves as Vice Chairman, President & CEO and a director.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Esquire Financial Holdings, Inc. reported an insider transaction by a senior executive who serves as Vice Chairman, President & CEO and a director. On December 9, 2025, the executive disposed of 5,181 shares of common stock at $104.04 in a transaction coded "F," leaving 276,237 shares beneficially owned directly.
These holdings include multiple grants of restricted stock that vest in three equal annual installments beginning on dates from December 19, 2023 through January 30, 2028. The executive also holds fully vested stock options covering 29,250 shares with a $12.50 exercise price, expiring on September 1, 2026.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise Price or Tax Liability | Common Stock | 5,181 | $104.04 | $539K |
| holding | Stock Options | -- | -- | -- |
Footnotes (7)
- F1. Includes shares of restricted stock which vest in three equal annual installments commencing on December 19, 2023.
- F2. Includes shares of restricted stock which vest in three equal annual installments commencing on December 16, 2024.
- F3. Includes shares of restricted stock which vest in three equal annual installments commencing on December 9, 2025.
- F4. Includes shares of restricted stock which vest in three equal annual installments commencing on December 19, 2026.
- F5. Includes shares of restricted stock which vest in three equal annual installments commencing on December 15, 2027.
- F6. Includes shares of restricted stock which vest in three equal annual installments commencing on January 30, 2028.
- F7. Stock options are fully vested.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Esquire Financial (ESQ) report on December 9, 2025?
On December 9, 2025, a senior Esquire Financial executive disposed of 5,181 shares of common stock at $104.04 in a transaction coded "F."
What is the role of the reporting person at Esquire Financial (ESQ)?
The reporting person is a director and also serves as Vice Chairman, President & CEO of Esquire Financial Holdings, Inc.
How do the restricted stock awards for Esquire Financial (ESQ) vest?
The beneficially owned shares include restricted stock that vests in three equal annual installments, with separate grants commencing on December 19, 2023, December 16, 2024, December 9, 2025, December 19, 2026, December 15, 2027, and January 30, 2028.
AI-generated analysis. How Rhea-AI works. Not financial advice.